×
About 18,793 results

ALLMedicine™ Hypoglycemia Center

Research & Reviews  5,596 results

ZT-01 - A Novel Somatostatin Receptor Antagonist for Restoring the Glucagon Response to...
https://doi.org/10.1111/dom.14652
Diabetes, Obesity & Metabolism; Farhat R, Aiken J et. al.

Jan 22nd, 2022 - Loss of the ability to secrete glucagon in longstanding type 1 (T1D) diabetes increases the susceptibility to hypoglycemia, but the mechanism for this loss remains unclear. Restoring the ability to secrete glucagon may be an effective means to pre...

Monitoring the Sequential Organ Failure Assessment score in nonocclusive mesenteric isc...
https://doi.org/10.1097/MD.0000000000028056
Medicine Murata T, Kawachi J et. al.

Jan 21st, 2022 - Several large-scale studies have assessed the endovascular and surgical treatments for nonocclusive mesenteric ischemia (NOMI); nonetheless, the prognostic factors for NOMI remain unclear.In this single-center study, we retrospectively reviewed th...

Risk factor analysis for type 2 diabetic patients about hypoglycemia using continuous g...
https://doi.org/10.1089/dia.2021.0465
Diabetes Technology & Therapeutics; Uemura F, Okada Y et. al.

Jan 21st, 2022 - To determine the relationship between hypoglycemia and glucose variability in outpatients with type 2 diabetes mellitus (T2DM). The study participants were 999 outpatients with T2DM who used the FreeStyle Libre Pro for continuous glucose monitorin...

Non-islet cell tumor hypoglycemia caused by breast tumor: A case report.
https://doi.org/10.1097/MD.0000000000027889
Medicine Zhou Z, Wei W et. al.

Jan 21st, 2022 - Non-islet cell tumor hypoglycemia (NICTH) generally refers to hypoglycemia caused by tumors other than islet cell tumors. Although hypoglycemia is a common clinical emergency, NICTH rarely occurs in patients with breast cancer. A 47-year-old woman...

Biomarker profiling of postmortem blood for diabetes mellitus and discussion of possibl...
https://doi.org/10.1007/s00414-021-02767-w 10.1038/nrendo.2011.183 10.3325/cmj.2015.56.181 10.1007/s00414-011-0625-y 10.1520/JFS15578J 10.5858/1999-123-0763-EOAFAH 10.2337/dc13-0610 10.1371/journal.pone.0040459 10.1021/ac101421b 10.1038/srep07796 10.1194/jlr.M400008-JLR200 10.1002/rcm.3947 10.1021/acs.jproteome.8b00169 10.1371/journal.pone.0105181 10.1007/s00414-017-1657-8 10.15761/IMM.1000278 10.1139/o59-099 10.1002/cpbi.11 10.1038/nmeth.339310.1038/nmeth.3393 10.1021/acs.analchem.6b00770 10.1007/BF02088748 10.1016/S0009-3084(99)00079-1 10.1038/nature13475 10.1161/ATVBAHA.108.168682 10.1371/journal.pone.0102641 10.1161/ATVBAHA.112.251538 10.1096/fj.201601225RR 10.2337/db08-1228 10.1007/s00125-009-1482-9 10.1038/sj.ijo.0801459 10.1210/jcem.81.8.8768851 10.1161/JAHA.116.004503 10.1016/j.metabol.2017.08.014 10.1016/S0021-9258(18)38001-3 10.1016/S0891-5849(98)00211-1 10.1016/S0009-3084(02)00101-9 10.1021/bi800786q 10.1016/j.freeradbiomed.2011.01.002 10.4239/wjd.v6.i3.456 10.1007/s00216-013-7534-5 10.1074/jbc.M110.137257 10.1111/j.1365-2265.2011.04244.x 10.1021/ac0481001
International Journal of Legal Medicine; Nariai M, Abe H et. al.

Jan 21st, 2022 - Acute metabolic disorders of diabetes mellitus (DM), such as diabetic ketoacidosis, hyperosmolar hyperglycemic state, and hypoglycemia, are life-threatening and difficult to diagnose postmortem owing to lack of macroscopic and microscopic findings...

see more →

Guidelines  11 results

Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation St...
https://doi.org/10.1001/jama.2021.11922
JAMA , Davidson KW et. al.

Aug 11th, 2021 - Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are us...

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diag...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268
Journal of Inherited Metabolic Disease; Altassan R, Radenkovic S et. al.

Jul 19th, 2020 - Phosphoglucomutase 1 (PGM1) deficiency is a rare genetic disorder that affects glycogen metabolism, glycolysis, and protein glycosylation. Previously known as GSD XIV, it was recently reclassified as a congenital disorder of glycosylation, PGM1-CD...

Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement ...
https://doi.org/10.1016/j.numecd.2019.07.017
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Pugliese G, Penno G et. al.

Oct 7th, 2019 - This joint document of the Italian Diabetes Society and the Italian Society of Nephrology reviews the natural history of diabetic kidney disease (DKD) in the light of the recent epidemiological literature and provides updated recommendations on an...

Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British...
https://doi.org/10.1177/0890334419846128
Journal of Human Lactation : Official Journal of Internat... Hawdon JM

May 6th, 2019 - Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British Association of Perinatal Medicine Framework for Practice, 2017.|2019|Hawdon JM,|prevention & control,prevention & control,standards,

see more →

Drugs  192 results see all →

Clinicaltrials.gov  405 results

Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III
https://clinicaltrials.gov/ct2/show/NCT05196165

Jan 19th, 2022 - The primary objective of this study is to evaluate the incidence of hypoglycemia in adult and pediatric participants with glycogen storage disease type III (GSD III).

Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)
https://clinicaltrials.gov/ct2/show/NCT04183868

Jan 13th, 2022 - Diabetes mellitus type 2 (T2DM) is the most common metabolic disease and its prevalence is rapidly increasing. T2DM is a chronic disease that affects over 451 million people in the world and this number is expected to increase over the years and i...

Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease (ESRD) Patients With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT04473430

Jan 11th, 2022 - The study is conducted to assess the efficacy of real-time CGM data in preventing hypoglycemia and hyperglycemia among patients with type 2 diabetes (DM2), treated with insulin and receiving hemodialysis. The study will provide novel insights into...

Gestational Diabetes and Pharmacotherapy (GAP)
https://clinicaltrials.gov/ct2/show/NCT03527537

Jan 11th, 2022 - Gestational diabetes mellitus (GDM) affects 5-8% of pregnant women, many of whom will require treatment beyond diet and exercise. Despite this high prevalence, there is no consensus regarding the glycemic threshold for conversion from diet to medi...

Cardiac Arrhythmia in Patients With End-Stage Renal Disease
https://clinicaltrials.gov/ct2/show/NCT04841304

Jan 11th, 2022 - The study will examine the presence of cardiac arrhythmias in patients receiving hemodialysis and the role of diabetes, hypoglycemia and parameters related to uremia and the dialysis procedure. The study is designed as a prospective cohort study w...

see more →

News  1,296 results

Artificial Pancreas Improves Glycemic Control in Young Kids With T1D
https://www.medpagetoday.com/endocrinology/type1diabetes/96749

Jan 19th, 2022 - A hybrid closed-loop system, also known as an artificial pancreas, improved glycemic control for very young kids with type 1 diabetes, the randomized KidsAP study confirmed. Among 74 kids ages 1 to 7 years, percentage of time in the target glucose...

'Artificial Pancreas' Life-Changing in Kids With Type 1 Diabetes
https://www.medscape.com/viewarticle/966813

Jan 19th, 2022 - A semi-automated insulin delivery system improved glycemic control in young children with type 1 diabetes aged 1 to 7 years without increasing hypoglycemia. "Hybrid closed-loop" systems — comprised of an insulin pump, a continuous glucose monitor ...

First-in-Class ADC Expands Portfolio of Precision Therapies in Bladder Cancer
https://www.onclive.com/view/firstinclass-adc-expands-portfolio-of-precision-therapies-in-bladder-cancer

Jan 3rd, 2022 - Bradley A. McGregor, MD The bladder cancer armamentarium gained a powerful agent in December 2019 with the approval of enfortumab vedotin-ejfv (Padcev), a Nectin-4—directed antibody-drug conjugate (ADC). The agency granted accelerated approval to...

A Cure for Type 1 Diabetes? Not yet, but We're Getting Closer
https://www.medscape.com/viewarticle/965208

Dec 30th, 2021 - This transcript has been edited for clarity. Recently, my patients have been asking me if there's a new cure for people with type 1 diabetes. This has been in the news and it was a front-page story in The New York Times. So, Is it true? In a word,...

Drugmakers Pushed Aggressive Diabetes Therapy. Patients Paid the Price
https://www.medscape.com/viewarticle/962273

Nov 5th, 2021 - CENTER CITY, Minnesota (Reuters) - Ron Carlson, like many Americans with diabetes, got the message trumpeted in drugmakers' unrelenting ads and reinforced by doctors: Use medications to lower your blood sugar to a specific target, and you can live...

see more →

Patient Education  17 results see all →